Global reinsurance capital grew 7% in 2020 – Willis Re
Total capital dedicated to the global reinsurance industry measured $658 billion at year-end 2020, reflecting 7 percent year-on-year growth, according to the latest Reinsurance Market Report from Willis Re.
The rise was driven primarily by strong investment market appreciation. New capital raised both by incumbents and new entrants added to the total, but capital returns to shareholders exceeded those new investments.
Willis Re conducted an in-depth analysis of the results of a subset of 17 reinsurers. The subset’s reported combined ratio deteriorated from 100.6 percent in 2019 to 104.1 percent in 2020, due entirely to COVID loss reserving. However, on an underlying basis, i.e., normalising COVID and natural catastrophe losses and excluding reserve releases, the combined ratio improved from 103.1 percent to 100.7 percent. This is the first full-year improvement in this ratio since at least 2014.
Return on equity (ROE), nevertheless, remains under pressure. The subset companies’ reported ROE fell from 9.7 percent to 2.7 percent, and the underlying ROE also fell from 3.2 percent to 1.3 percent. The underlying deterioration was due to declining investment yields more than offsetting the better underlying underwriting performance. On both a reported and underlying basis, the ROE remained well below the industry’s cost of capital.
James Kent, Global CEO, Willis Re, said: “Such a solid development of the global reinsurance industry’s capital base would hardly have been expected earlier last year, as the COVID pandemic was gathering pace. Willis Re’s analysis provides clear evidence of the strength and resilience of reinsurance market capacity. Reinsurers and insurers alike must contend with the challenges of low interest rates. But, looking through the turbulence of COVID and nat cat claims, and a declining reliance on reserve releases, there is a clear improving trend in underwriting profitability.”
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze